SureTrader SureTrader
Home > Boards > US Listed > Biotechs > Inovio Pharmaceuticals, Inc. (INO)

enough consolidating between >40 and .43....need to get

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Med.rare Member Profile
Member Level 
Followed By 22
Posts 2,484
Boards Moderated 1
Alias Born 03/28/01
160x600 placeholder
Inovio Pharmaceuticals Awarded $6.1 Million Sub-grant Through Wistar Institute to Develop DNA-based Monoclonal Antibodies Aga... "GlobeNewswire Inc." - 12/1/2016 9:00:00 AM
Inovio Applies to Cease Reporting to Canadian Securities Regulatory Authorities; NASDAQ Listing and US Reporting Unaffected "GlobeNewswire Inc." - 11/25/2016 8:00:00 AM
Inovio’s Co-Founder and Chair of its Scientific Advisory Board Selected as a Top 20 Translational Researcher "GlobeNewswire Inc." - 11/21/2016 8:00:00 AM
Inovio Wins Deloitte’s “Fast 500” Growth Award "GlobeNewswire Inc." - 11/16/2016 8:00:00 AM
Inovio’s Cancer Immunotherapy (INO-3112) Generates T Cell Immune Responses in Tumor Tissue and Peripheral Blood in Patients... "GlobeNewswire Inc." - 11/14/2016 7:00:00 AM
Inovio Pharmaceuticals Zika Vaccine Protects Animals from Infection, Brain Damage and Death "GlobeNewswire Inc." - 11/10/2016 10:00:00 AM
Inovio Pharmaceuticals Reports 2016 Third Quarter Financial Results "GlobeNewswire Inc." - 11/9/2016 7:30:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/9/2016 6:03:55 AM
Inovio Pharmaceuticals to Participate in Upcoming Investment Conferences "GlobeNewswire Inc." - 11/4/2016 8:00:00 AM
Inovio Pharmaceuticals to Report Third Quarter 2016 Financial Results November 9, 2016 "GlobeNewswire Inc." - 10/26/2016 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/24/2016 9:01:46 AM
Inovio Announces FDA Request for Additional Information For Phase III Program; Trial Initiation Delayed "GlobeNewswire Inc." - 10/24/2016 8:00:00 AM
Inovio CEO Selected As 2016 Healthcare Innovator "GlobeNewswire Inc." - 10/21/2016 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/14/2016 4:04:51 PM
Inovio Expands Executive Team to Advance its DNA Immunotherapy Product Portfolio "GlobeNewswire Inc." - 10/12/2016 8:00:00 AM
Inovio’s Zika Vaccine Selected As 2016 Technology Breakthrough "GlobeNewswire Inc." - 9/12/2016 8:00:00 AM
Inovio Pharmaceuticals to Present at Upcoming Investment Conferences "GlobeNewswire Inc." - 9/1/2016 9:05:08 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/30/2016 4:50:37 PM
Inovio Launches Zika Vaccine Trial in Midst of Puerto Rico Epidemic to Explore Early Signals of Vaccine Efficacy "GlobeNewswire Inc." - 8/29/2016 7:00:00 AM
Inovio Licenses Veterinary Foot and Mouth Disease Vaccine to Plumbline Life Sciences "GlobeNewswire Inc." - 8/16/2016 8:00:00 AM
Inovio Pharmaceuticals Expands Positive Phase I Ebola Vaccine Trial to Identify Most Optimal Immunization Regimen "GlobeNewswire Inc." - 8/11/2016 8:00:00 AM
GeneOne Life Science Announces Full Enrollment of First-In-Human Study of MERS Vaccine "GlobeNewswire Inc." - 8/8/2016 7:30:00 PM
Inovio Pharmaceuticals Reports 2016 Second Quarter Financial Results "GlobeNewswire Inc." - 8/8/2016 8:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/8/2016 6:03:33 AM
Inovio Pharmaceuticals Appoints Dr. Ami Shah Brown As Vice President Regulatory Affairs "GlobeNewswire Inc." - 8/4/2016 8:00:00 AM
Med.rare Member Level  Friday, 01/20/12 10:18:57 AM
Re: None
Post # of 13728 
enough consolidating between >40 and .43....need to get over the 50 dma at .46 and hold it,.lots of gains between there and the 200 dma at .66

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist